Cardinal Health, Inc. (NYSE:CAH) Shares Purchased by Tokio Marine Asset Management Co. Ltd.

Tokio Marine Asset Management Co. Ltd. increased its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 7.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,518 shares of the company’s stock after purchasing an additional 614 shares during the quarter. Tokio Marine Asset Management Co. Ltd.’s holdings in Cardinal Health were worth $859,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Ameriprise Financial Inc. boosted its position in shares of Cardinal Health by 82.2% during the 3rd quarter. Ameriprise Financial Inc. now owns 4,128,009 shares of the company’s stock worth $358,390,000 after acquiring an additional 1,862,291 shares in the last quarter. Northern Trust Corp boosted its position in shares of Cardinal Health by 0.9% during the 3rd quarter. Northern Trust Corp now owns 3,340,547 shares of the company’s stock worth $290,026,000 after acquiring an additional 28,412 shares in the last quarter. Pacer Advisors Inc. boosted its position in shares of Cardinal Health by 17.5% during the 4th quarter. Pacer Advisors Inc. now owns 2,619,561 shares of the company’s stock worth $264,052,000 after acquiring an additional 389,431 shares in the last quarter. AQR Capital Management LLC boosted its position in shares of Cardinal Health by 0.8% during the 3rd quarter. AQR Capital Management LLC now owns 2,496,531 shares of the company’s stock worth $216,749,000 after acquiring an additional 19,287 shares in the last quarter. Finally, California Public Employees Retirement System boosted its position in shares of Cardinal Health by 118.9% in the 4th quarter. California Public Employees Retirement System now owns 1,516,035 shares of the company’s stock valued at $152,816,000 after purchasing an additional 823,520 shares during the period. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Stock Performance

Shares of NYSE:CAH opened at $103.20 on Friday. The business’s fifty day moving average price is $109.51 and its two-hundred day moving average price is $104.67. The stock has a market cap of $25.10 billion, a PE ratio of 40.63, a price-to-earnings-growth ratio of 1.05 and a beta of 0.68. Cardinal Health, Inc. has a one year low of $77.56 and a one year high of $116.04.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, February 1st. The company reported $1.82 EPS for the quarter, beating analysts’ consensus estimates of $1.56 by $0.26. The firm had revenue of $57.45 billion for the quarter, compared to analysts’ expectations of $57.02 billion. Cardinal Health had a negative return on equity of 57.44% and a net margin of 0.30%. Cardinal Health’s quarterly revenue was up 11.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.32 EPS. As a group, equities research analysts predict that Cardinal Health, Inc. will post 7.28 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Monday, April 1st were given a $0.5006 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.94%. The ex-dividend date of this dividend was Thursday, March 28th. Cardinal Health’s dividend payout ratio (DPR) is currently 78.74%.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on CAH shares. SVB Leerink started coverage on Cardinal Health in a research report on Monday, February 26th. They issued an “outperform” rating and a $125.00 target price for the company. UBS Group upped their target price on Cardinal Health from $122.00 to $125.00 and gave the company a “buy” rating in a research report on Monday, February 5th. Barclays started coverage on Cardinal Health in a research report on Wednesday, January 3rd. They issued an “overweight” rating and a $117.00 target price for the company. Leerink Partnrs reissued an “outperform” rating on shares of Cardinal Health in a research report on Monday, February 26th. Finally, StockNews.com downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Wednesday. One research analyst has rated the stock with a sell rating, three have given a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, Cardinal Health currently has a consensus rating of “Moderate Buy” and an average target price of $103.07.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.